Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
DKA Leads to Changes in Children’s Cognitive Function
Glycemic and Adiposity Benefits with Metformin Use in Pregnancy
Letter from the Editor
When a child is newly diagnosed with type 1 diabetes we are often very careful to avoid hypoglycemia. Since many of these children will hit a honeymoon period, clinicians usually don’t strive for tight control for months. This seems like the right thing to do. Now, information from new studies published in the Journal of Pediatrics, Pediatric Diabetes and online, point to the need to be a little more aggressive in managing new onset diabetes in children to prevent DKA.
Our intern Alexandria Bartley from the FAMU College of Pharmacy looks at how just one DKA incident in a child can cause lifelong cognitive decline, in our Laterpay feature.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
TOP STORIES — Diabetes News and Research
Just one incident of DKA could potentially damage memory in children with type 1 diabetes.
A placebo-controlled trial was conducted to determine fetal, neonatal, and maternal outcomes associated with metformin use during pregnancy in women with T2DM.
People with diabetes may be predisposed to a variety of eating disorders, such as binge eating.
Fact: Half of Type 2 Diabetes Diagnoses from Obesity
Researchers found that obesity contributed to anywhere from 30% to 53% of new type 2 diabetes diagnoses among middle-aged and older Americans over nearly two decades. That higher percentage was seen in recent years, as the prevalence of obesity rose nationally. Trends in obesity and T2D run parallel to each other. The reasons for the link are not fully clear, but extra fat tissue may change body cells in a way that makes it harder for them to use insulin.
The findings, published Feb 10 in the Journal of the American Heart Association, are based on two large, ongoing studies tracking Americans’ health and lifestyle habits. One followed middle-aged and older adults for a decade, finding that almost 12% developed type 2 diabetes during that time. The odds were much higher among participants with obesity: 20% were diagnosed with diabetes, versus 7% of other adults. The other data source was the federal government’s National Health and Nutrition Examination Survey. Putting the two studies together, researchers calculated the number of new diabetes cases that could be attributed to obesity. By the end of the study period — 2013-2016 — an estimated 53% of diabetes diagnoses could be tied to obesity.
The effects were not uniform, however. Obesity had the most significant impact on white women’s diabetes risk and a lesser one for Black and Hispanic Americans.
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:
Alexandria Bartley, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences
Brianna Belton, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences
Shana Indawala, PharmD Candidate, University of South Florida Health, Taneja College of Pharmacy
Arjay Mendoza, PharmD Candidate, University of Colorado Denver Skaggs School of Pharmacy and Pharmaceutical Sciences
Nour Salhab, Pharm.D. Candidate, USF College of Pharmacy
Sandra Zaki, PharmD Candidate, Florida A&M University
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com